Skip to content

Product Surveillance Registry

Medtronic Product Surveillance Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01524276
Acronym
PSR
Enrollment
100000
Registered
2012-02-01
Start date
2012-01-01
Completion date
2040-01-01
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic, Peripheral Vascular and Venous Disorders, Cardiac Rhythm Disorders, Cardiovascular Disorders, Coronary Artery Disease, Diagnostic Techniques and Procedures, Digestive Disorders, Ear, Nose and Throat Disorder, Intracranial Aneurysm, Mechanical Circulatory Support, Minimally Invasive Surgical Procedures, Neurological Disorders, Neurovascular, Renal Insufficiency, Respiratory Therapy, Surgical Procedures, Operative, Urological Disorders

Brief summary

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

Interventions

None listed

Sponsors

Medtronic
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements * Patient has or is intended to receive or be treated with an eligible Medtronic product * Patient within enrollment window relative to therapy initiation or meets criteria for retrospective enrollment

Exclusion criteria

* Patient who is, or will be, inaccessible for follow-up * Patient with

Design outcomes

Primary

MeasureTime frame
Safety and Effectiveness of Market Released productsEvery 6-12 months (Therapy-dependent)

Countries

Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, Czechia, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Kuwait, Malaysia, Mexico, Netherlands, New Zealand, Norway, Panama, Poland, Portugal, Puerto Rico, Saudi Arabia, Serbia, Slovakia, South Korea, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States

Contacts

CONTACTMedtronic Product Surveillance Registry
rs.productsurveillanceregistry@medtronic.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026